Macrolides are a diverse family of naturally occurring and semi-synthetic antibiotics that are widely prescribed for treatment of various bacterial infections. They exert their antibacterial activity by inhibiting protein synthesis in pathogenic bacteria. In this program, a proprietary macrolide molecule has been identified that has excellent activity against M.tb and its analogues are being synthesized to improve potency and pharmacokinetics.